Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology
Authors:
Open Access
- 4 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1811435
Abstract
Objective: The relationship and underlying mechanisms linking the gut microbiota, metabolites and autism spectrum disorder (ASD) have not been fully elucidated. Methods: In the present study, network pharmacology was combined with machine learning for a systematic investigation into the possible action mechanisms between metabolites derived from the gut microbiota and their targets in ASD. Subsequently, untargeted metabolomics analysis and 16S rRNA sequencing were utilized for investigating alterations in differential metabolites and the composition of principal gut microbiota between normal and BTBR mice. Results: The findings demonstrated that five characteristic targets: CXCR3, HCAR2, HTR1A, IL-6 and NFKB1 modulated by the gut microbiota and gut microbiota’s metabolites were significantly associated with ASD. The M-S-M-T network prioritized 21 candidate gut-microbiota-derived metabolites, including phenylacetic acid and coumarin. These candidates were generated from database-based target prediction and should be interpreted separately from the differential metabolites detected in fecal metabolomics. Metabolomic and 16S rRNA sequencing analyses revealed that BTBR mice displayed metabolic dysregulation and disrupted gut microbiota composition compared with normal ones. These findings suggest that phenylalanine metabolism and neuroactive ligand-receptor interaction may be associated with ASD-like behavioral phenotypes in BTBR mice and warrant further experimental validation. The gut microbiota-metabolite-behavior network analysis further uncovered significant associations among the behavioral characteristics of ASD, alterations in gut microbiota composition and markedly altered metabolite profiles. Conclusion: By integrating network pharmacology, transcriptomic re-analysis, fecal metabolomics and 16S rRNA sequencing, this study identifies candidate microbe-metabolite-target associations related to ASD-like phenotypes. These results provide testable hypotheses for future mechanistic studies of gut-brain communication in ASD.Keywords
This publication has 71 references indexed in Scilit:
- Bacillus safensis NMCC-189 attenuates chronic restraint stress-induced depressive phenotypes and modulates neurochemical and gene expression changes in miceBiochemical and Biophysical Research Communications, 2026
- Cntn4 Gene Deficiency Promotes Autism-Like Phenotypes Associated with Gut Microbiota Perturbations and Gut-Brain Axis Metabolomic Alterations in MiceMolecular Neurobiology, 2025
- Mitochondrial dysfunction reveals H2S-mediated synaptic sulfhydration as a potential mechanism for autism-associated social defectsCell Metabolism, 2025
- Associations between the gut microbiota at one-year and neurodevelopment in children from the SEPAGES cohortBrain, Behavior, & Immunity - Health, 2025
- The relationship between neurodevelopmental disorders (NDDs) and NLRP3 inflammasomeInflammation Research, 2025
- Parabacteroides distasonis induces depressive-like behavior in a mouse model of Crohn’s diseaseBrain, Behavior, and Immunity, 2021
- The Roles of Serotonin in Neuropsychiatric DisordersCellular and Molecular Neurobiology, 2021
- Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in MiceCell, 2019
- Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of AutismEBioMedicine, 2017
- Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient miceJournal of NeuroVirology, 2017